Iterum Therapeutics plc

ITRM · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$9-$7-$5-$7
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$1-$0-$0-$1
Other Non-Cash$2$2$2$3
Operating Cash Flow-$8-$5-$3-$4
Investing Activities
PP&E Inv.-$0$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$1
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$0-$0$1
Financing Activities
Debt Repay.-$0$0$0$0
Stock Issued$6$5$6$14
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0-$15$0
Financing Cash Flow$6$5-$8$14
Forex Effect$0$0-$0-$0
Net Chg. in Cash-$2$0-$11$11
Supplemental Information
Beg. Cash$13$13$24$13
End Cash$11$13$13$24
Free Cash Flow-$8-$5-$3-$4